Arkolith/Insider Trading/ITRM/Form 4

Ahrens Brenton Karl

DirectorIterum Therapeutics plc (ITRM) · full profile →Form 4 · filed Sep 28, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 25, 2022Grant(A)15K$1.59$24K15K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-051422) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML